The comparative cycle in crosslinguistic perspective by Agnes Jäger

Get full text

Homologous Recombination Deficiency Testing for BRCA-Like Tumors: The Road to Clinical Validation by Marjolijn M. Ladan, Dik C. van Gent, Agnes Jager

Get full text

Hospital-based or home-based administration of oncology drugs? A micro-costing study comparing healthcare and societal costs of hospital-based and home-based subcutaneous administr... by Margreet Franken, Tim Kanters, Jules Coenen, Paul de Jong, Agnes Jager, Carin Uyl-de Groot

Get full text

Integrative whole-genome and transcriptome analysis of HER2-amplified metastatic breast cancer by Noortje Verschoor, Marcel Smid, Agnes Jager, Stefan Sleijfer, Saskia M. Wilting, John W. M. Martens

Get full text

A Systematic Review of the Use of Circulating Cell-Free DNA Dynamics to Monitor Response to Treatment in Metastatic Breast Cancer Patients by Elisabeth M. Jongbloed, Teoman Deger, Stefan Sleijfer, John W. M. Martens, Agnes Jager, Saskia M. Wilting

Get full text

Triple-Negative Breast Cancer and Predictive Markers of Response to Neoadjuvant Chemotherapy: A Systematic Review by Nadine S. van den Ende, Anh H. Nguyen, Agnes Jager, Marleen Kok, Reno Debets, Carolien H. M. van Deurzen

Get full text

Tamoxifen use and potential effects on liver parenchyma: A long‐term prospective transient elastographic evaluation by C. Louwrens Braal, Robert J. deKnegt, Agnes Jager, Stijn L. W. Koolen, Ron H. J. Mathijssen, Karel Eechoute

Get full text

Corrigendum to “The impact of menstruation persistence or recovery after chemotherapy on survival in young patients with hormone receptor negative breast cancer” [Breast 52 (2020)... by Mark van Barele, Bernadette A.M. Heemskerk-Gerritsen, Helena C. van Doorn, Marjanka K. Schmidt, Maartje J. Hooning, Agnes Jager

Get full text

Measuring Quality of Life Using Patient-Reported Outcomes in Real-World Metastatic Breast Cancer Patients: The Need for a Standardized Approach by Marloes E. Clarijs, Jacob Thurell, Friedrich Kühn, Carin A. Uyl-de Groot, Elham Hedayati, Maria M. Karsten, Agnes Jager, Linetta B. Koppert

Get full text

Patient-derived breast model repository, a tool for hyperthermia treatment planning and applicator design by Ioannis Androulakis, Kemal Sumser, Melanie N. D. Machielse, Linetta Koppert, Agnes Jager, Remi Nout, Martine Franckena, Gerard C. van Rhoon, Sergio Curto

Get full text

Estrogens and Progestogens in Triple Negative Breast Cancer: Do They Harm? by Mark van Barele, Bernadette A. M. Heemskerk-Gerritsen, Yvonne V. Louwers, Mijntje B. Vastbinder, John W. M. Martens, Maartje J. Hooning, Agnes Jager

Get full text

High-dose chemotherapy with stem cell rescue to treat stage III homologous deficient breast cancer: factors influencing clinical implementation by Joost G. E. Verbeek, Vincent M. T. de Jong, Hanna M. Wijnja, Agnes Jager, Sabine C. Linn, Valesca P. Retèl, Wim H. van Harten

Get full text

Cardiac monitoring in HER2-positive patients on trastuzumab treatment: A review and implications for clinical practice by Nathalie I. Bouwer, Agnes Jager, Crista Liesting, Marcel J.M. Kofflard, Jasper J. Brugts, Jos J.E.M. Kitzen, Eric Boersma, Mark-David Levin

Get full text

Health-related quality of life and productivity costs in breast cancer patients treated with tamoxifen in the Netherlands by Anne Kleijburg, C. Louwrens Braal, Justin D. Westenberg, Agnes Jager, Stijn L.W. Koolen, Ron H.J. Mathijssen, Carin A. Uyl-de Groot, Pim Wetzelaer, Hannah Penton

Get full text

High ctDNA molecule numbers relate with poor outcome in advanced ER+, HER2− postmenopausal breast cancer patients treated with everolimus and exemestane by Dinja T. Kruger, Maurice P.H.M. Jansen, Inge R.H.M. Konings, Wouter M. Dercksen, Agnes Jager, Jamal Oulad Hadj, Stefan Sleijfer, John W.M. Martens, Epie Boven

Get full text

Functional Ex Vivo Tissue-Based Chemotherapy Sensitivity Testing for Breast Cancer by Marjolijn M. Ladan, Titia G. Meijer, Nicole S. Verkaik, Zofia M. Komar, Carolien H. M. van Deurzen, Michael A. den Bakker, Roland Kanaar, Dik C. van Gent, Agnes Jager

Get full text

Proof-of-concept study linking ex vivo sensitivity testing to neoadjuvant anthracycline-based chemotherapy response in breast cancer patients by Marjolijn M. Ladan, Titia G. Meijer, Nicole S. Verkaik, Cecile de Monye, Linetta B. Koppert, Esther Oomen-de Hoop, Carolien H. M. van Deurzen, Roland Kanaar, Julie Nonnekens, Dik C. van Gent, Agnes Jager

Get full text

Toward model-informed precision dosing for tamoxifen: A population-pharmacokinetic model with a continuous CYP2D6 activity scale by Bram C. Agema, Sanne M. Buijs, Sebastiaan D.T. Sassen, Thomas E. Mürdter, Mathias Schwab, Birgit C.P. Koch, Agnes Jager, Ron H.N. van Schaik, Ron H.J. Mathijssen, Stijn L.W. Koolen

Get full text

Risk of metachronous contralateral breast cancer in patients with primary invasive lobular breast cancer: Results from a nationwide cohort by Delal Akdeniz, Iris Kramer, Carolien H. M. vanDeurzen, Bernadette A. M. Heemskerk‐Gerritsen, Michael Schaapveld, Pieter J. Westenend, Adri C. Voogd, Agnes Jager, Ewout W. Steyerberg, Stefan Sleijfer, Marjanka K. Schmidt, Maartje J. Hooning

Get full text

A phase 1b study evaluating the effect of elacestrant treatment on estrogen receptor availability and estradiol binding to the estrogen receptor in metastatic breast cancer lesions... by Agnes Jager, Elisabeth G. E. de Vries, C. Willemien Menke-van der Houven van Oordt, Patrick Neven, Clasina M. Venema, Andor W. J. M. Glaudemans, Yamei Wang, Rebecca G. Bagley, Maureen G. Conlan, Philippe Aftimos

Get full text